Ligand-independent AR phosphorylation and the subsequent activation, seen primarily in prostate cancers and breast and other cancer types, can be achieved through several RTKs, including EGFR family members [15,16,17,18]. This evidence concerns the gene EGFR and Familial prostate cancer.